CD209 - CD209 molecule Gene
Also Known as CDSIGN; CLEC4L; DC-SIGN; DC-SIGN1; hDC-SIGN
Species: Homo sapiens
About CD209
This gene has 11 transcripts (splice variants), 891 orthologues, 14 paralogues and is associated with 68 phenotypes. Broad expression in placenta (RPKM 11.4), lymph node (RPKM 9.5) and 17 other tissues.
Summary
This gene encodes a C-type lectin that functions in cell adhesion and pathogen recognition. This receptor recognizes a wide range of evolutionarily divergent pathogens with a large impact on public health, including leprosy and tuberculosis mycobacteria, the Ebola, hepatitis C, HIV-1 and Dengue viruses, and the SARS-CoV acute respiratory syndrome coronavirus. The protein is organized into four distinct domains: a C-terminal carbohydrate recognition domain, a flexible tandem-repeat neck domain, a transmembrane region and an N-terminal cytoplasmic domain involved in internalization. This gene is closely related in terms of both sequence and function to a neighboring gene, CLEC4M (Gene ID: 10332), also known as L-SIGN. The two genes differ in viral recognition and expression patterns, with this gene showing high expression on the surface of dendritic cells. Polymorphisms in the neck region are associated with protection from HIV-1 Infection, while single nucleotide polymorphisms in the promoter of this gene are associated with differing resistance and susceptibility to and severity of infectious disease, including rs4804803, which is associated with SARS severity. [provided by RefSeq, May 2020]
CD209 Products (7)
| mRNA | Protein | Name |
|---|---|---|
| NM_001144893.2 | NP_001138365.1 | CD209 antigen isoform 5 |
| NM_001144894.2 | NP_001138366.1 | CD209 antigen isoform 6 |
| NM_001144895.2 | NP_001138367.1 | CD209 antigen isoform 7 |
| NM_001144896.2 | NP_001138368.1 | CD209 antigen isoform 3 |
| NM_001144897.2 | NP_001138369.1 | CD209 antigen isoform 4 |
| NM_001144899.2 | NP_001138371.1 | CD209 antigen isoform 8 |
| NM_021155.4 | NP_066978.1 | CD209 antigen isoform 1 |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
12609975 | GOA |
| enables virus receptor activity |
IDA
IDA: Inferred from direct assay
|
22156524 | GOA |
| Biological Process GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| involved in B cell adhesion |
IDA
IDA: Inferred from direct assay
|
12421943 | GOA |
| involved in positive regulation of T cell proliferation |
IDA
IDA: Inferred from direct assay
|
12421943 | GOA |
| involved in positive regulation of viral life cycle |
IMP
IMP: Inferred from mutant phenotype
|
22673088 | GOA |
| acts upstream of or within regulation of T cell proliferation |
IDA
IDA: Inferred from direct assay
|
12456590 | GOA |
| involved in symbiont entry into host cell |
IDA
IDA: Inferred from direct assay
|
24623090 | GOA |
| Cellular Component GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| located in external side of plasma membrane |
IDA
IDA: Inferred from direct assay
|
24942581 | GOA |
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
12421943 | GOA |
CD209 Protein Structure
Lectin_C: Lectin C-type domain (274 - 379)
- 0
- 100
- 200
- 300
- 404 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
CD209 antigen |
|
CD209 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | Verweise |
|---|---|---|---|---|---|---|---|
|
Intra
|
CD209 | Q9NNX6 | VAC14 | Homo sapiens | Q08AM6 | 25416956 | |
|
Intra
|
CD209 | Q9NNX6 | VAC14 | Homo sapiens | Q08AM6 | 29892012 | |
|
Cross
|
CD209 | Q9NNX6 | Q03463-PRO_0000278734 | Hepatitis C virus | Q03463-PRO_0000278734 | 12609975 |
Recombinant CD209 Proteins
| Art. -Nr. | Produktname | Accession | Reinheit |
|---|---|---|---|
| HY-P70110 | DC-SIGN/CD209 Protein, Human (HEK293, Fc) | Q9NNX6-1 (Q59-A404) | ≥ 95%, as determined by reducing SDS-PAGE. |
CD209 Antibodies
| Art. -Nr. | Produktname | Anwendung | Reactivity |
|---|---|---|---|
| HY-P83614 | CD209 Antibody (YA3359) | WB | Human |
| HY-P84813 | CD209 Antibody (YA4510) | WB, FC, ELISA | Human |
| HY-P84813A | CD209 Antibody (YA4510)(PBS only) | WB, FC, ELISA | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Dengue Virus |
|
|
| Human Immunodeficiency Virus Type 1 |
|
|
| Rift Valley Fever |
|
|
| Japanese Encephalitis |
|
|
| Encephalitis |
|
|
| Measles |
|
|
| West Nile Virus |
|
|
| Dengue Disease |
|
|
| Herpes Simplex |
|
|
| Syphilis |
|
|
| Hepatitis C |
|
|
| Hand, Foot And Mouth Disease |
|
|
| Zika Fever |
|
|
| Papilloma |
|
|
| Lymphadenitis |
|
|
| Human Immunodeficiency Virus Infectious Disease |
|
|
| Paracoccidioidomycosis |
|
|
| Lymphocytic Choriomeningitis |
|
|
| Mycobacterium Tuberculosis 1 |
|
|
| Disease By Infectious Agent |
|
|
| Severe Acute Respiratory Syndrome |
|
|
| Aspergillosis |
|
|
| Chikungunya |
|
|
| Dengue Hemorrhagic Fever |
|
|
| Tick-Borne Encephalitis |
|
|
| Immune Deficiency Disease |
|
|
| Mouth Disease |
|
|
| Dengue Shock Syndrome |
|
|
| Ebola Hemorrhagic Fever |
|
|
| Viral Infectious Disease |
|
|
| Invasive Aspergillosis |
|
|
| Miyoshi Muscular Dystrophy 3 |
|
|
| Cutaneous Leishmaniasis |
|
|
| Tuberculoid Leprosy |
|
|
| West Nile Fever |
|
|
| Murray Valley Encephalitis |
|
|
| Lassa Fever |
|
|
| Lepromatous Leprosy |
|
|
| Leprosy 3 |
|
|
| Fungal Infectious Disease |
|
|
| Opportunistic Mycosis |
|
|
| Thrombocytopenia |
|
|
| Primary Bacterial Infectious Disease |
|
|
| Congenital Nervous System Abnormality |
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Rattus norvegicus | CD209 | RGD | RGD:1561104 |
| Others | CD209 | NCBI |